Perpetual Ltd Acquires Shares of 459,112 GE HealthCare Technologies Inc. $GEHC

Perpetual Ltd acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 459,112 shares of the company’s stock, valued at approximately $37,656,000.

Other large investors have also recently made changes to their positions in the company. E Fund Management Hong Kong Co. Ltd. raised its holdings in shares of GE HealthCare Technologies by 130.7% during the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after acquiring an additional 196 shares in the last quarter. Godsey & Gibb Inc. purchased a new position in shares of GE HealthCare Technologies in the third quarter valued at $26,000. Oakworth Capital Inc. increased its position in GE HealthCare Technologies by 1,876.2% in the third quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock worth $31,000 after purchasing an additional 394 shares during the last quarter. Piscataqua Savings Bank increased its position in GE HealthCare Technologies by 173.4% in the third quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after purchasing an additional 300 shares during the last quarter. Finally, Salomon & Ludwin LLC raised its stake in GE HealthCare Technologies by 326.5% during the third quarter. Salomon & Ludwin LLC now owns 482 shares of the company’s stock valued at $37,000 after purchasing an additional 369 shares in the last quarter. 82.06% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on GEHC shares. Bank of America increased their price objective on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the company a “neutral” rating in a research report on Monday, January 5th. Evercore boosted their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a report on Thursday, February 5th. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Piper Sandler lifted their price target on GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research report on Friday, January 30th. Finally, Citigroup reduced their price objective on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 11th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $92.17.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $70.35 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The company has a fifty day moving average of $76.89 and a two-hundred day moving average of $78.03. The firm has a market capitalization of $32.10 billion, a price-to-earnings ratio of 15.43, a PEG ratio of 1.55 and a beta of 1.17. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.04. The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is presently 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.